Javier Naval
6PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 29, 2025
Alisertib and Barasertib Induce Cell Cycle Arrest and Mitochondria-Related Cell Death in Multiple Myeloma with Enhanced Efficacy Through Sequential Combination with BH3-Mimetics and Panobinostat.Andrea Benedi, Manuel Beltrán-Visiedo, Nelia Jiménez-Alduán
|Sep 13, 2023
Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-XL in multiple myeloma cell lines partially dependent on MCL-1 and in plasma cells from patients.Manuel Beltrán-Visiedo, Nelia Jiménez-Alduán, Rosana Díez
|Mar 11, 2023
Study of the Bcl-2 Interactome by BiFC Reveals Differences in the Activation Mechanism of Bax and Bak.Óscar Gonzalo, Andrea Benedi, Laura Vela
|Nov 07, 2022
Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis.Alfonso Serrano Del Valle, Manuel Beltrán-Visiedo, Victoria de Poo-Rodríguez
|Feb 15, 2022
Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma.Chantal Reina-Ortiz, David Giraldos, Gemma Azaceta
|Apr 03, 2019
Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy.Javier Naval, Diego de Miguel, Ana Gallego-Lleyda
Pageof 1
Frequent Collaborators
5 joint publications
Alberto Anel
5 joint publications
Isabel Marzo
2 joint publications
Alfonso Serrano-Del Valle
2 joint publications
Manuel Beltrán-Visiedo
2 joint publications
Nelia Jiménez-Alduán
2 joint publications
Gemma Azaceta
2 joint publications
Luis Palomera
2 joint publications
Andrea Benedi
1 joint publications
Chantal Reina-Ortiz
1 joint publications
David Giraldos
